Yorvipath: payments to doctors
Payments that named Yorvipath as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 4,035
- Transactions
- 10,864
- Average per transaction
- $179
The per-transaction average — $179 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,035 providers the average total is $482, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | $1,925,802 | 99.1% |
| Ascendis Pharma Inc | $17,539 | 0.9% |